Epidermal Growth Factor Receptor Mutation Status and Rad51 Determine the Response of Glioblastoma to Multimodality Therapy With Cetuximab, Temozolomide, and Radiation

Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2013.00013

Related search